Search - tctmd.com

Displaying 201 - 220 of 311

Sort: Relevancy | Date

Presentation

ICSS-MRI Analysis: Ischemic Brain Lesions After CAS Increase Future Cerebrovascular Risk

Presenter: H. Gensicke

February 08, 2015

Presentation

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

Presenter: O.A. Berkhemer

December 16, 2014

Presentation ICI 2014

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Presenter: Amir Belson

December 14, 2014

Presentation ICI 2014

SPG Stimulation for Treatment of Acute Ischemic Stroke

Presenter: Yoram Solberg

December 14, 2014

Presentation

New Ischemic Stroke and Outcomes With Vorapaxar vs Placebo

Presenter: B.P. Bonaca

December 02, 2014

Presentation Cardiovascular Interventions 2014

Stem Cells for Ischemic Heart Disease

Presenter: Richard A. Shatz

October 23, 2014

Presentation TCT 2014

TCT 176: Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Shows a Significant Reduction in Risk

Presenter: John M. Lasala, Stuart J. Pocock, George Hanzel, MD

September 16, 2014

Presentation TCT 2014

TCT 482: Effect of Cangrelor on Ischemic Endpoints: Further Analyses From CHAMPION PHOENIX

Presenter: John M. Lasala, Stuart J. Pocock, Deepak L. Bhatt

September 16, 2014

Presentation TCT 2014

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Presenter: Alok Saurav

September 16, 2014

Presentation TCT 2014

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Presenter: Deepak Bhatt

September 16, 2014

Presentation TCT 2014

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Presenter: George Hanzel

September 16, 2014

Presentation TCT 2014

Complete revascularization in ischemic heart failure may improve patient survival

Presenter: Lukasz Pyka

September 16, 2014

Presentation TCT 2014

Vagal Nerve Neuromodulation for Ischemic HF Therapy

Presenter: Daniel Burkhoff, Felix Mahfoud, Jose Luis Assad-Morell, Sahil A. Parikh, Gaetano De Ferrari

September 15, 2014

Presentation TCT 2014

TCT 75: Complete Revascularization in Ischemic Heart Failure May Improve Patient Survival

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Lukasz Pyka

September 15, 2014

Presentation TCT 2014

TCT 76: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute® Device in Patients with Ischemic Dilated Heart Failure: Primary Endpoint Results of the European Postmarket Trial - PARACHUTE III

Presenter: Vasken Dilsizian, Sunil V. Rao, Jose P.S. Henriques, Ulrich Schaefer, MD

September 15, 2014

Presentation TCT 2014

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Presenter: Frank Litvack, Todd J. Brinton

September 14, 2014

Presentation

Impact of the System and Physician Factors on the Detection of Obstructive CAD with Diagnostic Angiography in Stable Ischemic Heart Disease

Presenter: Harindra C. Wijeysundera

September 11, 2014

Presentation

Door-to-Needle (DTN) Times for tPA and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative

Presenter: Gregg C. Fonarow

April 23, 2014

Presentation

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Presenter: Sripal Bangalore

April 22, 2014

Presentation

Adipose-Derived Regenerative Cells in Patients with Ischemic Cardiomyopathy

Presenter: E.C. Perin

April 21, 2014

Advertisement

ICSS-MRI Analysis: Ischemic Brain Lesions After CAS Increase Future Cerebrovascular Risk

A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

SPG Stimulation for Treatment of Acute Ischemic Stroke

New Ischemic Stroke and Outcomes With Vorapaxar vs Placebo

Stem Cells for Ischemic Heart Disease

TCT 176: Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Shows a Significant Reduction in Risk

TCT 482: Effect of Cangrelor on Ischemic Endpoints: Further Analyses From CHAMPION PHOENIX

Impact of Ischemic Post-Conditioning on Infarct Size and Clinical Outcomes in Primary Percutaneous Coronary Intervention: A Meta-analysis of 26 Randomized Controlled Trials

Effect of Cangrelor on Ischemic Endpoints: Further Analyses from CHAMPION PHOENIX

Comparison of Imputed Placebo Versus Observed Ischemic Stroke Rates in the Watchman Trials Represents a Significant Reduction in Risk

Complete revascularization in ischemic heart failure may improve patient survival

Vagal Nerve Neuromodulation for Ischemic HF Therapy

TCT 75: Complete Revascularization in Ischemic Heart Failure May Improve Patient Survival

TCT 76: Percutaneous Ventricular Restoration (PVR) Therapy Using the Parachute® Device in Patients with Ischemic Dilated Heart Failure: Primary Endpoint Results of the European Postmarket Trial - PARACHUTE III

Therapeutic Hypothermia: A Novel Noninvasive Approach to Facilitate a Paradigm Shift in Care for Ischemic Disease

Impact of the System and Physician Factors on the Detection of Obstructive CAD with Diagnostic Angiography in Stable Ischemic Heart Disease

Door-to-Needle (DTN) Times for tPA and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative

Heparin Monotherapy or Bivalirudin During PCI in NSTE-ACS or Stable Ischemic Heart Disease

Adipose-Derived Regenerative Cells in Patients with Ischemic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content